Thor Medical ASA (FRA:8NN) Change In Inventory: €-0.26 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8NN Thor Medical ASA FRA:8NN
27 GF Score
Price €0.52
! 4 Warning Signs
View Full Analysis

What is Thor Medical ASA Change In Inventory?

Thor Medical ASA FRA:8NN -1.89% 27 Change In Inventory is €-0.26 Mil as of Dec. 2025. GuruFocus rates FRA:8NN with a GF Score™ of 27/100. The stock has 4 warning signs investors should review.

Thor Medical ASA's change in inventory for the quarter that ended in Dec. 2025 was €-0.03 Mil. It means Thor Medical ASA's inventory increased by €0.03 Mil from Jun. 2025 to Dec. 2025 .

Thor Medical ASA's change in inventory for the fiscal year that ended in Dec. 2025 was €-0.25 Mil. It means Thor Medical ASA's inventory increased by €0.25 Mil from Dec. 2024 to Dec. 2025 .

Thor Medical ASA's Total Inventories for the quarter that ended in Dec. 2025 was €0.25 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Thor Medical ASA's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Thor Medical ASA's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 6.97.


Thor Medical ASA  (FRA:8NN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Thor Medical ASA's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.237/0*365 / 2
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Thor Medical ASA's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Thor Medical ASA's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thor Medical ASA Change In Inventory Related Terms


Thor Medical ASA Change In Inventory Historical Data

* Premium members only.

The historical data trend for Thor Medical ASA's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA Change In Inventory Chart

Thor Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.25

Thor Medical ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.22 -0.03
FRA:8NN
27GF Score
Thor Medical ASA FRA:8NN
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thor Medical ASA Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-0.26 Mil mean?
Thor Medical ASA (FRA:8NN) has a Change In Inventory of €-0.26 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Thor Medical ASA and its competitors.
Is Thor Medical ASA's Change In Inventory too high?
Thor Medical ASA's current Change In Inventory is €-0.26 Mil. Overall, Thor Medical ASA has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Thor Medical ASA's Change In Inventory compare to VRTX and REGN?
Thor Medical ASA's Change In Inventory of €-0.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Thor Medical ASA and its competitors. Thor Medical ASA's current Change In Inventory is €-0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thor Medical ASA stock overvalued right now?
Thor Medical ASA (FRA:8NN) has a current Change In Inventory of €-0.26 Mil. The current Change In Inventory is €-0.26 Mil. Thor Medical ASA's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Thor Medical ASA (FRA:8NN), the current Change In Inventory is €-0.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thor Medical ASA Business Description

Other Exchanges TRMED:Norway0R6Y:UK
Address Drammensveien 167, Oslo, NOR, 0277
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.
27GF Score

Get the complete analysis for FRA:8NN

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.52
Price